相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Pyrrolopyrimidine inhibitors of DNA gyrase B (GyrB) and topoisomerase IV (ParE). Part I: Structure guided discovery and optimization of dual targeting agents with potent, broad-spectrum enzymatic activity
Leslie W. Tari et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2013)
Pyrrolopyrimidine inhibitors of DNA gyrase B (GyrB) and topoisomerase IV (ParE), Part II: Development of inhibitors with broad spectrum, Gram-negative antibacterial activity
Micheal Trzoss et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2013)
Distinguishing On-Target versus Off-Target Activity in Early Antibacterial Drug Discovery Using a Macromolecular Synthesis Assay
Mark L. Cunningham et al.
JOURNAL OF BIOMOLECULAR SCREENING (2013)
Pyrrolamide DNA Gyrase Inhibitors: Fragment-Based Nuclear Magnetic Resonance Screening To Identify Antibacterial Agents
Ann E. Eakin et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2012)
Exploiting bacterial DNA gyrase as a drug target: current state and perspectives
Frederic Collin et al.
APPLIED MICROBIOLOGY AND BIOTECHNOLOGY (2011)
Pyrrolamide DNA gyrase inhibitors: Optimization of antibacterial activity and efficacy
Brian A. Sherer et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2011)
Challenges of Antibacterial Discovery
Lynn L. Silver
CLINICAL MICROBIOLOGY REVIEWS (2011)
Assessing the Performance of the Molecular Mechanics/Poisson Boltzmann Surface Area and Molecular Mechanics/Generalized Born Surface Area Methods. II. The Accuracy of Ranking Poses Generated From Docking
Tingjun Hou et al.
JOURNAL OF COMPUTATIONAL CHEMISTRY (2011)
In front of and behind the replication fork: bacterial type IIA topoisomerases
Claudia Sissi et al.
CELLULAR AND MOLECULAR LIFE SCIENCES (2010)
DNA gyrase (GyrB)/topoisomerase IV (ParE) inhibitors: Synthesis and antibacterial activity
Stephen P. East et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2009)
Comparison of Nine Programs Predicting pKa Values of Pharmaceutical Substances
Chenzhong Liao et al.
JOURNAL OF CHEMICAL INFORMATION AND MODELING (2009)
AutoDock4 and AutoDockTools4: Automated Docking with Selective Receptor Flexibility
Garrett M. Morris et al.
JOURNAL OF COMPUTATIONAL CHEMISTRY (2009)
Antibiotics for Emerging Pathogens
Michael A. Fischbach et al.
SCIENCE (2009)
Physical Insights into Permeation of and Resistance to Antibiotics in Bacteria
Matteo Ceccarelli et al.
CURRENT DRUG TARGETS (2008)
Novel dual-targeting benzimidazole urea inhibitors of DNA gyrase and topoisomerase IV possessing potent antibacterial activity: Intelligent design and evolution through the judicious use of structure-guided design and stucture-activity relationships
Paul S. Charifson et al.
JOURNAL OF MEDICINAL CHEMISTRY (2008)
Phaser crystallographic software
Airlie J. McCoy et al.
JOURNAL OF APPLIED CRYSTALLOGRAPHY (2007)
Dual targeting of GyrB and ParE by a novel aminobenzimidazole class of antibacterial compounds
Trudy H. Grossman et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2007)
In vitro characterization of the antibacterial spectrum of novel bacterial type II topoisomerase inhibitors of the aminobenzimidazole class
N Mani et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2006)
Glide: A new approach for rapid, accurate docking and scoring. 1. Method and assessment of docking accuracy
RA Friesner et al.
JOURNAL OF MEDICINAL CHEMISTRY (2004)
Crystal structures of Escherichia coli topoisomerase IV ParE subunit (24 and 43 kilodaltons):: a single residue dictates differences in novobiocin potency against topoisomerase IV and DNA gyrase
S Bellon et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2004)
Where will new antibiotics come from?
C Walsh
NATURE REVIEWS MICROBIOLOGY (2003)
Structure validation by Cα geometry:: φ,ψ and Cβ deviation
SC Lovell et al.
PROTEINS-STRUCTURE FUNCTION AND GENETICS (2003)
DNA gyrase interaction with coumarin-based inhibitors:: The role of the hydroxybenzoate isopentenyl moiety and the 5′-methyl group of the noviose
D Lafitte et al.
BIOCHEMISTRY (2002)
Emerging mechanisms of fluoroquinolone resistance
DC Hooper
EMERGING INFECTIOUS DISEASES (2001)
The fluoroquinolone antibacterials: past, present and future perspectives
PC Appelbaum et al.
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2000)
Novel inhibitors of DNA gyrase: 3D structure based biased needle screening, hit validation by biophysical methods, and 3D guided optimization. A promising alternative to random screening
HJ Boehm et al.
JOURNAL OF MEDICINAL CHEMISTRY (2000)
GHKL, an emergent ATPase/kinase superfamily
R Dutta et al.
TRENDS IN BIOCHEMICAL SCIENCES (2000)
分享论文
